Prof. Breymann - Medical Advisor at ETH start-up DIAXXO

GYN & PERINATAL ZURICH > Prof. Breymann - Medical Advisor at ETH-Start-Up DIAXXO

Together with Dr. Stefan Meier, Dr. Gianluigi Berini and Charles Tschaggeny, I am pleased to be able to actively support the start-up as an "advisor" in strategic and scientific questions and solutions.

DIAXXO from Zurich

Founded in 2020, DIAXXO AG is a spin-off company that emerged from the Functional Materials Lab at ETH Zurich.

DIAXXO envisions a future where accurate and reliable diagnoses are available everywhere and to everyone. They believe that point-of-care PCR tests will enable doctors to detect and fight diseases more quickly and experts to perform DNA analyses much faster.

diaxxo.com

Does hormone replacement therapy affect the risk of breast cancer?

1 August 2020

There is an ongoing debate and it depends on which supplements you use. Surprisingly, there are even situations where menopausal hormone replacement therapy (MHT) can reduce the risk of breast cancer. According to research, many women who...

Read more

Prof. Breymann - Specialist for "gentle caesarean section".

1 July 2020

Whether it is a question of uncomplicated pregnancies or high-risk pregnancies - the competent practice team accompanies the patients from the beginning of the pregnancy to the birth. Individual peculiarities are recognised and taken into account with great sensitivity in order to ensure the optimal development of the child...

Read more

At what age should hormone replacement therapy be started?

1 June 2020

The most important thing is not to start before the menopause. The body must manifest symptoms of a deficiency of certain substances. It is necessary to measure and assess hormone levels and only then make a decision. Many women come...

Read more
Load more